Distinct Roles of ?7 nAChRs in Antigen-Presenting Cells and CD4+ T Cells in the Regulation of T Cell Differentiation.
Ontology highlight
ABSTRACT: It is now apparent that immune cells express a functional cholinergic system and that ?7 nicotinic acetylcholine receptors (?7 nAChRs) are involved in regulating T cell differentiation and the synthesis of antigen-specific antibodies and proinflammatory cytokines. Here, we investigated the specific function ?7 nAChRs on T cells and antigen presenting cells (APCs) by testing the effect of GTS-21, a selective ?7 nAChR agonist, on differentiation of CD4+ T cells from ovalbumin (OVA)-specific TCR transgenic DO11.10 mice activated with OVA or OVA peptide323-339 (OVAp). GTS-21 suppressed OVA-induced antigen processing-dependent development of CD4+ regulatory T cells (Tregs) and effector T cells (Th1, Th2, and Th17). By contrast, GTS-21 up-regulated OVAp-induced antigen processing-independent development of CD4+ Tregs and effector T cells. GTS-21 also suppressed production of IL-2, IFN-?, IL-4, IL-17, and IL-6 during OVA-induced activation but, with the exception IL-2, enhanced their production during OVAp-induced activation. In addition, during antigen-nonspecific, APC-independent anti-CD3/CD28 antibody-induced CD4+ polyclonal T cell activation in the presence of respective polarizing cytokines, GTS-21 promoted development of all lineages, which indicates that GTS-21 also acts via ?7 nAChRs on T cells. These results suggest 1) that ?7 nAChRs on APCs suppress CD4+ T cell activation by interfering with antigen presentation through inhibition of antigen processing; 2) that ?7 nAChRs on CD4+ T cells up-regulate development of Tregs and effector T cells; and that ?7 nAChR agonists and antagonists could be potentially useful agents for immune response modulation and enhancement.
SUBMITTER: Mashimo M
PROVIDER: S-EPMC6554293 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA